Capecitabine

Cat. No.: PI154361509

Description: Capecitabine is an oral chemotherapy medication used to treat breast cancer, colorectal cancer, and other cancers. It is a prodrug of 5-fluorouracil (5-FU), which is a pyrimidine analog that interferes with DNA synthesis. Capecitabine is converted to 5-FU in the liver, and it then works by blocking the growth of cancer cells.

Product Details

CAS	154361-50-9
Molecular Formula	C15H22FN3O6
Molecular Weight	359.35
Uses	Capecitabine is indicated as treatment for a variety of cancer types. For colorectal cancer, capecitabine is indicated as a single agent or a component of a combination chemotherapy regiment for the adjuvant treatment of stage III colon cancer and treatment unresectable or metastatic colorectal cancer. It can also be used as a part of a combination chemotherapy perioperative treatment of adult locally advanced rectal cancer. For breast cancer, capecitabine is indicated for advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated or as a regimen with docetaxel after disease progression on prior anthracycline-containing chemotherapy. For gastric, esophageal, or gastroesophageal junction (GEJ) cancer, capecitabine is indicated as a component of a combination chemotherapy treatment for the treatment of adult unresectable or metastatic gastric, esophageal, or GEJ cancer or adult HER2-overexpressing metastatic gastric or GEJ adenocarcinoma who have not received prior treatment for metastatic disease. Finally, for pancreatic cancer, capecitabine is indicated as adjuvant treatment for adult pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.

* Our products are for research use only.

Capecitabine

Get in Touch